Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LiRen Tu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Telomere fusions in early human breast carcinomaHiromi Tanaka, Satoshi Abe, Nazmul Huda, et al.
Molecular Carcinogenesis|April 29, 2015
Widespread telomere instability in prostatic lesionsLiRen Tu, Nazmul Huda, Brenda R Grimes, et al.
Stem Cell Reports|September 21, 2013
The luminal progenitor compartment of the normal human mammary gland constitutes a unique site of telomere dysfunctionNagarajan Kannan, Nazmul Huda, Liren Tu, et al.
EMBO Molecular Medicine|March 15, 2012
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53Chris T Williamson, Eiji Kubota, Jeffrey D Hamill, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Telomere fusions in early human breast carcinomaHiromi Tanaka, Satoshi Abe, Nazmul Huda, et al.
Molecular Carcinogenesis|April 29, 2015
Widespread telomere instability in prostatic lesionsLiRen Tu, Nazmul Huda, Brenda R Grimes, et al.
Stem Cell Reports|September 21, 2013
The luminal progenitor compartment of the normal human mammary gland constitutes a unique site of telomere dysfunctionNagarajan Kannan, Nazmul Huda, Liren Tu, et al.
EMBO Molecular Medicine|March 15, 2012
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53Chris T Williamson, Eiji Kubota, Jeffrey D Hamill, et al.
Pageof 1